-
46 patients primary malignant glioma cohort in Chinese population
Study
EGAS00001005583
-
Multi-omics of Richter syndrome
Study
EGAS00001005495
-
Analysis of RAD51C promoter methylation using targeted bisulfite sequencing (amplicon sequencing) in ovarian cancer pre-clinical models and patient samples.
Study
EGAS00001005395
-
Cell type-specific transcriptomics of esophageal adenocarcinoma as a scalable alternative for single cell transcriptomics
Study
EGAS00001004053
-
Evolutionary dynamics of neuroblastoma
Study
EGAS00001004990
-
Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing
Study
EGAS00001005420
-
Patient-derived neuroblastoma model system OHC-NB1
Study
EGAS00001003031
-
Sequence Data from the phase 2 PrE0505 trial of Durvalumab with First Line Platinum-Pemetrexed for Unresectable Pleural Mesothelioma
Study
EGAS00001005426
-
Intellance-2: omics data on recurrent glioblastoma patients participating in the Intellance-2 clinical trial, prior to treatment.
Study
EGAS00001005437
-
Whole genome sequencing (bam files) of 5 samples of myxofibrosarcoma and 5 matched pairs
Study
EGAS00001005444
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__head___neck
Study
EGAS00001005450
-
MM samples for epigenomic translocation of H3K4me3 broad domains following super-enhancer hijacking
Study
EGAS00001005684
-
DERMATLAS__Hidradenoma_papilliferum_RNAseq
Study
EGAS00001005715
-
IMCISION DNAseq
Study
EGAS00001005466
-
Cancer immune control needs senescence induction by Stat1 dependent cell cycle regulator pathways in tumours
Study
EGAS00001004151
-
Characterization of DLBCL with a PMBL gene expression signature
Study
EGAS00001005057
-
Immune profiling reveals enrichment of distinct immune signatures in high-risk oral potentially malignant disorders
Study
EGAS00001005520
-
'KOREAN' never-smoker female adenocarcinoma RNA-seq
Study
EGAS00001003789
-
Transcriptional changes in GBM through therapy
Study
EGAS00001003790
-
Targeted sequencing data and shallow whole genome sequencing data of Follicular lymphoma.
Study
EGAS00001005755
-
Single-cell RNA-seq data of the tumor microenvironment of lymphocyte-rich Hodgkin lymphoma and other Hodgkin lymphoma subtypes
Study
EGAS00001005541
-
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity through a pathogenic lipid metabolism-mTOR circuit - 10x Genomics scRNAseq
Study
EGAS00001005098
-
Clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancers defined by genomic analysis
Study
EGAS00001005784
-
Sequencing of cancer autopsies and ctDNA
Study
EGAS00001005109
-
The genomic landscape of early stage ovarian high grade serous carcinoma
Study
EGAS00001005567
-
Whole genome sequencing of multiple myeloma identifies novel structural and non-coding mutations.
Study
EGAS00001003164
-
RNA-seq on neuroblastoma PDX model COG-N-519 treated with control miR-1283 and test miR-99b-5p mimics
Study
EGAS00001005581
-
Brain_Disease_Wellcome_Leap_Delta_Tissue_RNA
Study
EGAS00001005800
-
Integrative molecular analysis of pediatric Anaplastic large cell lymphoma reveals subtypes with distinct immune suppression signatures.
Study
EGAS00001004189
-
Analysis of exonic somatic variants in light-chain amyloidosis (ALA) and ALA concomitant with multiple myeloma
Study
EGAS00001004214
-
Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes
Study
EGAS00001004235
-
Gene expression-based prediction of pazopanib efficacy in sarcoma (HIPO, H021)
Study
EGAS00001005836
-
Whole-exome sequencing of ovarian clear cell carcinoma in clinical outliers
Study
EGAS00001004248
-
Multiplexed quantification of four neuroblastoma DNA targets in a single droplet digital PCR reaction
Study
EGAS00001004275
-
Single-nuclei gene-expression analysis of pheochromocytoma and paraganglioma links tumor subtypes with tumor microenvironment
Study
EGAS00001005861
-
Short and long-read genome sequencing methodologies for somatic variant detection; genomic analysis of a patient with diffuse large B-cell lymphoma
Study
EGAS00001004266
-
Analysis of IDHwt-glioblastoma samples from paired primary and recurrent tumor samples
Study
EGAS00001003184
-
Coding and non-coding drivers of mantle cell lymphoma identified through exome and genome sequencing
Study
EGAS00001004289
-
Origins and timing of emerging lesions in advanced renal cell carcinoma
Study
EGAS00001005897
-
Efficacy of CDK4/6i in preclinical models of malignant pleural mesothelioma
Study
EGAS00001005352
-
The Landscape of Genetic Alterations in Hepatocellular Carcinoma, 88 matched HCC tumour/normal pairs WGS belongs to ICGC LICA-CN project
Study
EGAS00001002218
-
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma (arrays set)
Study
EGAS00001004314
-
Single-cell RNA sequencing of 6 follicular lymphoma tumors
Study
EGAS00001005257
-
Comprehensive molecular characterization of brainstem glioma
Study
EGAS00001004341
-
Sclerosing epithelioid fibrosarcoma case report
Study
EGAS00001005215
-
Enhanced reduced representation bisulfite sequencing (eRRBS) on 45 multiple myeloma samples and 3 normal plasma cell
Study
EGAS00001004348
-
Control samples, breast cancer clinical samples and matched patient-derived tumour xenografts (PDTXs) to develop and test a computational approach to discriminate human and mouse sequences in PDTXs
Study
EGAS00001002445
-
Genetic Risk for Subsequent Neoplasms among Long-term Survivors of Childhood Cancer in the St. Jude Lifetime Cohort
Study
EGAS00001002499
-
Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Study
EGAS00001005222
-
Esophageal Adenocarcinoma Organoid Genomics
Study
EGAS00001005224
-
Molecular programs of melanoma brain metastases (MBM)
Study
EGAS00001005976
-
Targeted-capture sequencing (bam files) of 81 samples of myxofibrosarcoma and 44 matched pairs
Study
EGAS00001005443
-
Combined clinical and gene expression score identifies high-risk individuals among follicular lymphoma patients on immunotherapy
Study
EGAS00001002566
-
Reduced Representation Bisulfite Sequencing (RRBS) in various tissues to discover DNA methylation markers for the diagnosis of breast and ovarian cancer.
Study
EGAS00001002609
-
Sequencing of an adolescent patient with germline RET mutant alveolar rhabdomyosarcoma
Study
EGAS00001004359
-
Gene expression profiling of nasopharyngeal carcinoma
Study
EGAS00001004542
-
Comprehensive Genomic Characterization of Refractory Multiple Myeloma Reveals a Complex Mutational and Structural Landscape Associated with Drug Resistance (H067)
Study
EGAS00001004363
-
Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
Study
EGAS00001004366
-
Fibroblast heterogeneity drives metastatic spread in breast cancer through distinct mechanisms
Study
EGAS00001003238
-
tFL with a PMBL GE signature
Study
EGAS00001005870
-
Alveolar Rhabdomyosarcoma sequencing data
Study
EGAS00001005387
-
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Study
EGAS00001005981
-
CM214 - Biomarker Analysis From the Phase 3 CheckMate 214 Trial of Nivolumab Plus Ipilimumab (N+I) or Sunitinib (S) in Advanced Renal Cell Carcinoma (aRCC)
Study
EGAS00001005501
-
Cerebrospinal fluid circulating tumour DNA allows the characterisation and monitoring of medulloblastoma
Study
EGAS00001004651
-
Embryonal Rhabdomyosarcoma sequencing data
Study
EGAS00001005502
-
Multiple Myeloma Total Therapy trial patient sequencing
Study
EGAS00001003223
-
Patient-derived tumor organoids for personalized medicine in a rare case of hepatocellular carcinoma with neuroendocrine differentiation.
Study
EGAS00001005887
-
Neuroblastoma and adrenal gland single-cell study
Study
EGAS00001004388
-
Single cell copy number and chromatin accessibility in primary multiple myeloma cells
Study
EGAS00001005382
-
Integrative Profiling of T790M Negative EGFR Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities
Study
EGAS00001005389
-
Functional dissection of inherited non-coding variation influencing multiple myeloma risk
Study
EGAS00001005394
-
A mechanistic classification of clinical phenotypes in neuroblastoma
Study
EGAS00001003244
-
Pediatric Papillary Thyroid Carcinoma RNA-Seq
Study
EGAS00001005182
-
Overactivation of the IGF signalling pathway in osteosarcoma
Study
EGAS00001004767
-
Characterizing the immune and genome landscapes for osteosarcoma
Study
EGAS00001003247
-
Single-cell analysis for metastatic gastric adenocarcinoma
Study
EGAS00001004443
-
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Study
EGAS00001004445
-
Genomic characterization of co-existing biliary tract intraepithelial neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer
Study
EGAS00001005402
-
Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma
Study
EGAS00001003251
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Breast cohort
Study
EGAS00001004446
-
WES cutaneous and uveal melanoma liver metastases
Study
EGAS00001004795
-
CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase
Study
EGAS00001004455
-
Cabozantinib Response in ETV6-NTRK3 G623R Positive Carcinoma HIPO-021
Study
EGAS00001004494
-
Mutational_burden_in_human_hair_follicles
Study
EGAS00001004462
-
Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients
Study
EGAS00001003255
-
Single cell RNA sequencing of normal endometrial derived organoids uncovers novel cell type markers for prognostication
Study
EGAS00001004466
-
Targeted sequencing of diffuse large B-cell lymphoma tumour samples from the UK's Haematological Malignancy Research Network
Study
EGAS00001005953
-
ENCORAFENIB COMBINED WITH BINIMETINIB FOR BRAFV600E-MUTATED RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE PHASE II GMMG-BIRMA TRIAL (Hipo_K08K)
Study
EGAS00001005973
-
An epigenetic single-cell atlas of IDH-mutant glioma reveals the role of ATRX in shaping tumor composition
Study
EGAS00001004523
-
Changes in alternative splicing and associated neo-antigens due to therapy
Study
EGAS00001004524
-
Conserved interferon-gamma signaling and decreased immune exclusion programs in responses to immune checkpoint blockade therapy
Study
EGAS00001004545
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM67 WES
Study
EGAS00001004555
-
Novel mutations in TOP2A in gliomas
Study
EGAS00001004556
-
Cancer and germline exomes, and cancer RNA-seq consisiting of FASTQ paired-end reads from melanoma, lung and colon cancer samples
Study
EGAS00001005513
-
Dedifferentiated_Melanoma
Study
EGAS00001003471
-
Dynamic N6-methyladenosine Epitranscriptomic Landscape in Lung Adenocarcinoma
Study
EGAS00001005524
-
Failure of Differentiation of the Rhombic Lip Constitutes Medulloblastoma
Study
EGAS00001005826
-
Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocarcinogenesis
Study
EGAS00001004629
-
USARC 10X Genomics Single Cell DNA Sequencing Data
Study
EGAS00001006144